Lung Cancer Clinical Trials in Albuquerque, NM

View the best 10 lung cancer medical studies in Albuquerque, New Mexico. Access promising new therapies by applying to a Albuquerque-based Lung Cancer clinical trial.

Trials in Albuquerque, New Mexico

Here are the top 10 medical studies for lung cancer in Albuquerque, New Mexico

Hypofractionated Radiation Therapy

Radiation

Recruiting1 awardPhase 2

This trial is testing the safety and effectiveness of a new cancer treatment that involves radiation therapy followed by immunotherapy with atezolizumab.

FSRS +1 More

Radiation Therapy

Recruiting1 award

This trial evaluates if a lower radiation dose over multiple days reduces side effects vs. one day of full radiation dose for cancer patients on immunotherapy.

Docetaxel +1 More

Anti-microtubule agent

Recruiting2 awardsPhase 3

This trial is testing a new drug, sigvotatug vedotin, against a standard drug, docetaxel, in patients with advanced lung cancer. The goal is to see if the new drug works better and to understand its side effects. Docetaxel (Taxotere) is a well-established chemotherapy agent used in the treatment of advanced non-small cell lung cancer (NSCLC), often after failure of first-line treatments.

Pembrolizumab

Checkpoint Inhibitor

Recruiting2 awardsPhase 3

"This trial is testing pembrolizumab with chemotherapy followed by pembrolizumab alone or with another drug for treating advanced lung cancer. The goal is to see if adding the second drug helps

AZD8205

Chemotherapy

Recruiting1 awardPhase 1 & 2

This trial is testing a new drug called AZD8205 to see if it can help treat advanced or spreading solid tumors. The study includes patients whose cancer is advanced or has spread and may not respond to current treatments. AZD8205 might work by stopping or slowing down the growth of cancer cells.

HLX10

Monoclonal Antibodies

Recruiting3 awardsPhase 3

This trial is testing two different treatment combinations for patients with extensive-stage small cell lung cancer who have not received any prior treatment. One group will receive a new drug called Serplulimab along with standard chemotherapy, while the other group will receive an existing drug called Atezolizumab with the same chemotherapy. Both immunotherapy drugs aim to help the immune system fight cancer, and the chemotherapy drugs work by killing cancer cells. Atezolizumab has been shown to improve survival in small-cell lung cancer when combined with chemotherapy, changing the standard first-line therapy.

Sotorasib

Targeted Therapy

Recruiting2 awardsPhase 2

This trial studies the effect of AMG 510 in treating patients with KRAS G12C mutated non-squamous non-small cell lung cancer.

Screening Platform

Genomic Screening

Recruiting1 awardPhase 2 & 3

This trial will test new targeted cancer therapies against standard of care therapy in order to find more effective treatments.

Thoracotomy +1 More

Procedure

Recruiting2 awardsPhase 3

This trial compares the effect of open thoracic surgery to thoracoscopic surgery in treating patients with osteosarcoma that has spread to the lung.

Carboplatin +4 More

Alkylating agents

Recruiting2 awardsPhase 3

This trial is testing the addition of the immunotherapy drug pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB IIIA or IIIB non-small cell lung cancer.

Popular Filters

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?

Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).

Is there any support for travel costs?

Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.

Will I know what medication I am taking?

This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.

How long do clinical trials last?

Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.

Do you verify all the trials on your website?

All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.

How quickly will I hear back from a clinical trial?

Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.

1045 Sansome St, Suite 321, San Francisco, CA

hello@withpower.com (415) 900-4227

Conditions

Locations

Psychology Related

Treatments

Cities

Lung Cancer Clinical Trials in Albuquerque, NM

Trials in Albuquerque, New Mexico

Hypofractionated Radiation Therapy

Radiation

This trial is testing the safety and effectiveness of a new cancer treatment that involves radiation therapy followed by immunotherapy with atezolizumab.

FSRS +1 More

Radiation Therapy

This trial evaluates if a lower radiation dose over multiple days reduces side effects vs. one day of full radiation dose for cancer patients on immunotherapy.